Atorvastatin Calcium Tablet, Film Coated
NDC Package 59651-606-30
Package Information
Atorvastatin Calcium tablets are indicated:To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adults with primary hyperlipidemia. This formulation utilizes a tablet, film coated delivery system. Marketed by Aurobindo Pharma Limited, this product is identified by NDC 59651-606 and is authorized under FDA application ANDA217118.
Identification & Billing
- RxCUI: 259255 - atorvastatin calcium 80 MG Oral Tablet
- RxCUI: 259255 - atorvastatin 80 MG Oral Tablet
- RxCUI: 259255 - atorvastatin (as atorvastatin calcium) 80 MG Oral Tablet
- RxCUI: 617310 - atorvastatin calcium 20 MG Oral Tablet
- RxCUI: 617310 - atorvastatin 20 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 59651 - Aurobindo Pharma Limited
- 59651-606 - Atorvastatin Calcium
- 59651-606-30 - 30 TABLET, FILM COATED in 1 BOTTLE
- 59651-606 - Atorvastatin Calcium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (59651-606). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59651-606-30 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Atorvastatin Calcium, a human prescription drug labeled by Aurobindo Pharma Limited. This tablet, film coated is formulated for oral use and contains atorvastatin calcium trihydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aurobindo Pharma Limited on February 13, 2024. The current certification is valid through December 31, 2027.
How is this Aurobindo Pharma Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59651060630. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.